Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review.
Petelytska L, Bonomi F, Cannistrà C, Fiorentini E, Peretti S, Torracchi S, Bernardini P, Coccia C, De Luca R, Economou A, Levani J, Matucci-Cerinic M, Distler O, Bruni C.
Petelytska L, et al.
RMD Open. 2023 Nov;9(4):e003426. doi: 10.1136/rmdopen-2023-003426.
RMD Open. 2023.
PMID: 37940340
Free PMC article.
These results emphasise the need for developing a standardised, consensus definition of severe SSc-ILD, to link a disease specific definition of progression as a surrogate outcome for clinical trials and clinical practice.PROSPERO registration number CRD42022379254.Cite No …
These results emphasise the need for developing a standardised, consensus definition of severe SSc-ILD, to link a disease specific definitio …